
NFTRH+; A Medical Diagnostics Seasonal Bottom Play
This one has shown up occasionally on watch in the NFTRH+ Charts & Notes segment and today it finally came aboard my portfolio. It’s a company with a lot of moving parts as it invests and divests to realign its business with a growth strategy in the diagnostic testing area. As you can see, the market did not care too much for its latest earnings … Continue reading NFTRH+; A Medical Diagnostics Seasonal Bottom Play